COVID-19: ‘Contagion to this world’ and the demand for ethical research

By Julian C. Hughes and Julian Sheather. COVID-19 has indeed, to quote Hamlet, brought, ‘Contagion to this world’. Less than a month after it was first reported, the Nuffield Council on Bioethics (NCoB) issued its report, Research in Global Health Emergencies: Ethical Issues. In its discussion of the ethical issues raised by global health emergencies, […]

Read More…

Covid-19, Patents & Healthcare: The Need for A (Bio)ethics Space within Patent Law

By Aisling McMahon. Covid-19 was declared a pandemic on 12th March 2020 and by 9th April had claimed 81,580 lives. Covid-19 has also brought to stark reality broader inequalities and impediments in the delivery of healthcare, including the potential impacts of patents. Patents are intellectual property rights which allow the patent holder to stop others […]

Read More…

Prioritizing justice in ventilator allocation

By L. Syd M Johnson As the Covid-19 pandemic intensified worldwide, grim reports out of Italy’s embattled and overwhelmed hospitals foretold the need to plan for rationing ventilators in the event that the number of patients requiring them exceeded the number available. Hospitals, ethics committees, and government agencies around the US began planning for the […]

Read More…

Hydroxychloroquine and Critically Ill Patients with COVID-19: The role of Healthcare Professionals

By Joseph Adetola Adedigba and Sarah Perou Hermans. Currently, there are no Food and Drug Administration (FDA) approved pharmaceutical treatments for COVID-19, and this has led to speculations concerning the efficacy of various experimental drugs and combinations. Hydroxychloroquine has been promoted as a potential treatment for COVID-19 by United States President Donald J. Trump. On […]

Read More…

Not only benefit: equity and fairness in states’ responses to COVID-19

By Nic Aagaard, Lynley Anderson, Neil Pickering A range of important ethical considerations that have arisen due to the emergence of the novel coronavirus COVID-19. A potentially important part of the international response is the role of National Ethics Committees (NECs). NECs are generally advisory committees, offering ethical comment to governments and other institutions, and […]

Read More…

Towards meaningful human control. Using artificial intelligence in clinical decision making

By Matthias Braun, Patrik Hummel, Susanne Beck, Peter Dabrock Clinical decision-making can be challenging. The subject matter is complex. Decisions can have incisive, long-lasting consequences. There is imperfect evidence and informational asymmetries between those involved. Time constraints and economic restrictions complicate the process further. In view of difficulties like these, it is tempting to deploy […]

Read More…

DNACPRs and advance care planning in the COVID19 pandemic: key lessons

By Catriona McMillan and Victoria Sobolewska  Patient-doctor discussions surrounding do not attempt cardio-pulmonary resuscitation (DNACPR) orders amidst the COVID-19 pandemic have caused widespread, understandable panic in the UK, set against a backdrop of proportionately higher elderly deaths, discussions surrounding resource allocation (particularly with reference to ventilators), and emerging stories of rising care home deaths. Here, […]

Read More…

Laissez COVID19 faire, laissez COVID19 passer?

By Gabriela Arguedas Ramírez Pandemics are threshold situations that put our individual and collective convictions, priorities and capacities to the test. They test state institutions, the ethical principles that have guided the formation of public policy and the strengths and weaknesses of our social fabric. Pandemics are ethical-political issues and not simply medical or biological […]

Read More…